SAB Biotherapeutics News and Activities

Acquisition, funding and merger involving SAB Biotherapeutics.

• SAB Biotherapeutics has just announced a $175 Million fundraising (posted on July 22 2025).

View the org chart displaying its 28 main executives

Most searched biographies at SAB Biotherapeutics

• Samuel Reich, Executive Chairman of the Board and Chief Executive ...
• Jay Skyler, Director
• Katie Ellias, Director

Popular executive movements at SAB Biotherapeutics

• David Zaccardelli has joined the company as Chairman of the Board  (posted on January 9 2026).
• Rita Jain has joined the company as Independent Director  (posted on January 9 2026).

Create your alert
to follow the executive moves at SAB Biotherapeutics.

SAB Biotherapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by SAB Biotherapeutics

• Presentations | SAB Biotherapeutics
• Events | SAB Biotherapeutics
• News Releases | SAB Biotherapeutics
• Big Cypress Acquisition Corp Announces Special Meeting of Stockholders to Approve Business Combination with SAB Biotherapeutics - SAb Biotherapeutics

Social media about SAB Biotherapeutics

• SAB Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• SAB Biotherapeutics on LinkedIn, X (Twitter) & YouTube